BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 22461787)

  • 1. New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy.
    Soler MJ; Riera M; Batlle D
    Exp Diabetes Res; 2012; 2012():616313. PubMed ID: 22461787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelial nitric oxide synthase in diabetic nephropathy: lessons from diabetic eNOS knockout mice.
    Takahashi T; Harris RC
    J Diabetes Res; 2014; 2014():590541. PubMed ID: 25371905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting Experimental Models of Diabetic Nephropathy.
    Giralt-López A; Molina-Van den Bosch M; Vergara A; García-Carro C; Seron D; Jacobs-Cachá C; Soler MJ
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse models of diabetic nephropathy.
    Breyer MD; Böttinger E; Brosius FC; Coffman TM; Harris RC; Heilig CW; Sharma K;
    J Am Soc Nephrol; 2005 Jan; 16(1):27-45. PubMed ID: 15563560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal Models of Diabetes-Associated Renal Injury.
    Noshahr ZS; Salmani H; Khajavi Rad A; Sahebkar A
    J Diabetes Res; 2020; 2020():9416419. PubMed ID: 32566684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent animal models: from mild to advanced stages of diabetic nephropathy.
    Kaur M; Bedi O; Sachdeva S; Reddy BV; Kumar P
    Inflammopharmacology; 2014 Oct; 22(5):279-93. PubMed ID: 25149089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modelling diabetic nephropathy in mice.
    Azushima K; Gurley SB; Coffman TM
    Nat Rev Nephrol; 2018 Jan; 14(1):48-56. PubMed ID: 29062142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Kidney Injury and Progression of Diabetic Kidney Disease.
    Yu SM; Bonventre JV
    Adv Chronic Kidney Dis; 2018 Mar; 25(2):166-180. PubMed ID: 29580581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A family-based strategy to identify genes for diabetic nephropathy.
    Covic AM; Iyengar SK; Olson JM; Sehgal AR; Constantiner M; Jedrey C; Kara M; Sabbagh E; Sedor JR; Schelling JR
    Am J Kidney Dis; 2001 Mar; 37(3):638-47. PubMed ID: 11228193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines in diabetic nephropathy.
    Wu CC; Sytwu HK; Lin YF
    Adv Clin Chem; 2012; 56():55-74. PubMed ID: 22397028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in murine models of diabetic nephropathy.
    Kong LL; Wu H; Cui WP; Zhou WH; Luo P; Sun J; Yuan H; Miao LN
    J Diabetes Res; 2013; 2013():797548. PubMed ID: 23844375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rodent models to study type 1 and type 2 diabetes induced human diabetic nephropathy.
    Talukdar A; Basumatary M
    Mol Biol Rep; 2023 Sep; 50(9):7759-7782. PubMed ID: 37458869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERp44 depletion exacerbates ER stress and aggravates diabetic nephropathy in db/db mice.
    Pang X; Zhang Y; Shi X; Li D; Han J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):921-926. PubMed ID: 30224065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular basement membrane duplication is a predictor of the prognosis of diabetic nephropathy in patients with type 2 diabetes.
    Yamakawa T; Kawaguchi T; Kitamura H; Kadomura M; Nishimura M; Yokoo T; Imasawa T
    Clin Exp Nephrol; 2019 Apr; 23(4):521-529. PubMed ID: 30467801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
    J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes mellitus as a cause or comorbidity of chronic kidney disease and its outcomes: the Gonryo study.
    Iwai T; Miyazaki M; Yamada G; Nakayama M; Yamamoto T; Satoh M; Sato H; Ito S
    Clin Exp Nephrol; 2018 Apr; 22(2):328-336. PubMed ID: 28752289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGLT2 Inhibitors and the Diabetic Kidney.
    Fioretto P; Zambon A; Rossato M; Busetto L; Vettor R
    Diabetes Care; 2016 Aug; 39 Suppl 2():S165-71. PubMed ID: 27440829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.